Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Frontiers in Endocrinology
|
August 2, 2023
Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches
Nick Giannoukakis, Kyle S McCommis
Biochimica Et Biophysica Acta
|
November 9, 2011
The role of VDAC in cell death: friend or foe?
Kyle S McCommis, Christopher P Baines
Cellular and Molecular Gastroenterology and Hepatology
|
January 29, 2019
Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
Kyle S McCommis, Brian N Finck
Endocrinology
|
December 15, 2020
The Importance of Keeping Time in the Liver
Kyle S McCommis, Andrew A Butler
Expert Opinion on Investigational Drugs
|
February 6, 2025
Metabolic dysfunction and insulin sensitizers in acute and chronic disease
Jerry R Colca, Kyle S McCommis
The Journal of Physiology
|
March 21, 2022
Hepatic stellate cells in physiology and pathology
Dakota R Kamm, Kyle S McCommis
The Biochemical Journal
|
March 10, 2015
Mitochondrial pyruvate transport: a historical perspective and future research directions
Kyle S McCommis, Brian N Finck
Biomolecules
|
February 25, 2023
The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease
Kyle S McCommis, Brian N Finck
Hepatology Communications
|
September 24, 2021
Two Faces of Pioglitazone: Sorting Out the Roles of its PPARγ Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple
Liyun Yuan, Kyle S McCommis, Brent A Neuschwander-Tetri
The Journal of Physiology
|
March 1, 2021
CrossTalk opposing view: Ketone bodies are not an important metabolic fuel for the heart
Manoja K Brahma, Adam R Wende, Kyle S McCommis
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Frontiers in Endocrinology
|
August 2, 2023
Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches
Nick Giannoukakis, Kyle S McCommis
Biochimica Et Biophysica Acta
|
November 9, 2011
The role of VDAC in cell death: friend or foe?
Kyle S McCommis, Christopher P Baines
Cellular and Molecular Gastroenterology and Hepatology
|
January 29, 2019
Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
Kyle S McCommis, Brian N Finck
Endocrinology
|
December 15, 2020
The Importance of Keeping Time in the Liver
Kyle S McCommis, Andrew A Butler
Expert Opinion on Investigational Drugs
|
February 6, 2025
Metabolic dysfunction and insulin sensitizers in acute and chronic disease
Jerry R Colca, Kyle S McCommis
The Journal of Physiology
|
March 21, 2022
Hepatic stellate cells in physiology and pathology
Dakota R Kamm, Kyle S McCommis
The Biochemical Journal
|
March 10, 2015
Mitochondrial pyruvate transport: a historical perspective and future research directions
Kyle S McCommis, Brian N Finck
Biomolecules
|
February 25, 2023
The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease
Kyle S McCommis, Brian N Finck
Hepatology Communications
|
September 24, 2021
Two Faces of Pioglitazone: Sorting Out the Roles of its PPARγ Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple
Liyun Yuan, Kyle S McCommis, Brent A Neuschwander-Tetri
The Journal of Physiology
|
March 1, 2021
CrossTalk opposing view: Ketone bodies are not an important metabolic fuel for the heart
Manoja K Brahma, Adam R Wende, Kyle S McCommis
Page
of 8